Skip to content

Drug interactions

Mavacamten + Topiramate

Severity: Moderate

Mavacamten and Topiramate: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Topiramate is a weak CYP2C19 inhibitor and may raise mavacamten exposure. Higher mavacamten levels can reduce left ventricular ejection fraction and increase the risk of heart failure.

What this interaction means in plain words

Mavacamten and Topiramate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mavacamten belongs to Cardiovascular; Topiramate belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Inhibition of CYP2C19-mediated metabolism of mavacamten by topiramate.

What to do

Monitor left ventricular ejection fraction closely when topiramate is started or stopped, and follow labeled echocardiographic monitoring. Adjust the mavacamten dose according to LVEF and clinical response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mavacamten and Topiramate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mavacamten with Topiramate?

MediHelp rates the interaction as moderate. Mavacamten and Topiramate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Topiramate is a weak CYP2C19 inhibitor and may raise mavacamten exposure. Higher mavacamten levels can reduce left ventricular ejection fraction and increase the risk of heart failure.

How serious is the interaction between Mavacamten and Topiramate?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor left ventricular ejection fraction closely when topiramate is started or stopped, and follow labeled echocardiographic monitoring. Adjust the mavacamten dose according to LVEF and clinical response.

What other medicines interact with Topiramate?

MediHelp also lists interactions of Topiramate with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Topiramate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in